2632. Duration of viable SARS-CoV-2 shedding in immunocompromised COVID-19 patients during the widespread vaccination era

BACKGROUND: Individuals with COVID-19 who are immunocompromised have been reported to experience prolonged shedding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) compared to those who are immunocompetent. However, it remains unclear how long viable SARS-CoV-2 shedding persists...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanai, Osamu, Fujita, Kohei, Hata, Hiroaki, Odagaki, Takao, Mio, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677139/
http://dx.doi.org/10.1093/ofid/ofad500.2244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677139/
http://dx.doi.org/10.1093/ofid/ofad500.2244

Ejemplares similares